Biocytogene - BioContact e.V. (English) https://www.biocontact.info/en/tag/biocytogen/ We network science and industry Mon, 09 Feb 2026 17:35:26 +0000 en-GB hourly 1 https://wordpress.org/?v=7.0 In CONTACT with Biocytogen 2026 https://www.biocontact.info/en/in-contact-with-biocytogen-2026/ Mon, 09 Feb 2026 17:35:09 +0000 https://www.biocontact.info/en/?p=4933 👤 Format: English, Hybrid (in-person attendance is strongly encouraged)🗓️ Date & Time: 19.02.2026, Thursday – 6 pm📍 Location: DKFZ Communication Center, Seminar Room K1/K2  Speaker: Francesco Cortopassi, Ph.D. - Business Development

Der Beitrag In CONTACT with Biocytogen 2026 erschien zuerst auf BioContact e.V. (English).

]]> 👤 Format: English, Hybrid (in-person attendance is strongly encouraged)
🗓️ Date & Time: 19.02.2026, Thursday – 6 pm
đź“Ť Location: DKFZ Communication Center, Seminar Room K1/K2
🎤  Speaker: Francesco Cortopassi, Ph.D. - Business Development Manager

Discover the latest trends in cancer target validation and learn how next-generation humanized mouse models help researchers move faster, work smarter, and get closer to the clinic. This dynamic session highlights  in vivo models, ADC-focused platforms, and real-world case studies supporting preclinical cancer research, from target discovery to translational validation.

Biocytogen is a global biotech company advancing antibody drug discovery through innovative platforms. Its RenBiologics™ portfolio delivers fully human antibody modalities across 1,000+ targets, while BioMice™ offers 4,000+ humanized models and integrated in vivo, ex vivo, and in vitro pharmacology and gene-editing services.

See you on the 19th of February!

Der Beitrag In CONTACT with Biocytogen 2026 erschien zuerst auf BioContact e.V. (English).

]]>